Orencia
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
577 Main St, Islip Manor, New York, 1175...Phone Number
(631) 252-1636Website
www.orencia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Orencia
ORENCIA SC and IV is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. ORENCIA may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (DMARDs) other than tumor necrosis factor (TNF) antagonists. ORENCIA IV is indicated for reducing signs and symptoms in pediatric patients 6 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis. ORENCIA IV may be used as monotherapy or concomitantly with methotrexate (MTX). ORENCIA SC has not been studied in pediatric patients. ORENCIA should not be administered concomitantly with TNF antagonists. ORENCIA is not recommended for use concomitantly with other biologic rheumatoid arthritis (RA) therapy, such as anakinra.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orencia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Orencia had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Orencia
Orencia, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Orencia launches new products
Check out if Orencia is spiking on competitors!
Funding: Get notified immidiatlly once Orencia has new funding data
Check if Orencia has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Orencia recently announced quarterly report
Recommended Actions
Find VP level buyers at Orencia
Find 2 more new buyers
Compare Similar Companies to Orencia
Compare insights from companies similar to Orencia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Orencia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orencia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orencia.
Orencia Tech Stack
A closer look at the technologies used by Orencia
Orencia News & Media
Bristol-Myers Squibb Reports Third Quarter Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Reports Third Quarter Financial ResultsBristol-Myers Squibb Reports Second Quarter Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Reports Second Quarter Financial Results
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Orencia
Sign Up For FreeTo access detailed company insights
ORENCIA SC and IV is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. ORENCIA may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (... Read More
